An example of successful chemo-immunotherapy is the combination of platinum CTX with PD-1/PD-L1 inhibitors [31,32,33], which has now become the standard 1st-line option for advanced PD-L1+ non-small cell lung cancer [34]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.